FDA’s Crawford Outlines DSHEA “Umbrella Strategy” For Supplements
This article was originally published in The Tan Sheet
Executive Summary
FDA expects to issue a draft guidance shortly to clarify the type of evidence needed to substantiate labeling claims for dietary supplements